Lanean...
Nimotuzumab plus platinum-based chemotherapy platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma
Background: Palliative chemotherapy has been the mainstay treatment for patients with recurrent or metastatic nasopharyngeal carcinoma (R/M-NPC). However, little is known about the efficacy and toxicity of nimotuzumab (NTZ) – a monoclonal antibody drug targeting epidermal growth factor receptor – pl...
Gorde:
| Egile Nagusiak: | , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SAGE Publishing
2020-09-01
|
| Saila: | Therapeutic Advances in Medical Oncology |
| Sarrera elektronikoa: | https://doi.org/10.1177/1758835920953738 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|